Microbiota and bile acid profiles in retinoic acid-primed mice that exhibit accelerated liver regeneration

Oncotarget

Volumn 7, Issue 2, 2016, Pages 1096-1106

  Liu, Hui Xin ^a   Hu, Ying ^a   Wan, Yu Jui Yvonne ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Energy metabolism; Fibroblast growth factor 21; Gut liver axis; Lipid homeostasis; Partial hepatectomy; Pathology Section

Indexed keywords

APICAL SODIUM DEPENDENT BILE ACID TRANSPORTER; BILE ACID; BINDING PROTEIN; CARRIER PROTEIN; CHOLESTEROL 7ALPHA MONOOXYGENASE; CYCLIN A; CYCLIN B; CYCLIN D; CYCLIN E; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 15; FIBROBLAST GROWTH FACTOR 21; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; ILEAL BILE ACID BINDING PROTEIN; KI 67 ANTIGEN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; ORGANIC ANION TRANSPORTER 2; ORGANIC SOLUTE TRANSPORTER BETA; RETINOIC ACID; SIRTUIN 1; TAUROCHOLIC ACID; UNCLASSIFIED DRUG; MITOGEN ACTIVATED PROTEIN KINASE;

AKKERMANSIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIUM; BACTEROIDETES; BIFIDOBACTERIUM; BILE ACID HOMEOSTASIS; C57BL 6 MOUSE; CELL METABOLISM; CELL PROLIFERATION; CHEMICAL COMPOSITION; COMPARATIVE STUDY; CONTROLLED STUDY; CYCLIN A GENE; CYCLIN B GENE; CYCLIN D GENE; CYCLIN E GENE; DRUG MECHANISM; ENERGY HOMEOSTASIS; FIRMICUTES; GENE EXPRESSION PROFILING; HOMEOSTASIS; INTESTINE FLORA; INTRACELLULAR SIGNALING; LACHNOSPIRACEAE; LACTOBACILLUS; LIPID EMULSIFICATION; LIPID HOMEOSTASIS; LIPID METABOLISM; LIPID STORAGE; LIVER CELL; LIVER REGENERATION; MALE; MICROBIAL COMMUNITY; MICROFLORA; MOUSE; NONHUMAN; RUMINOCOCCACEAE; SOLUBILITY; VERRUCOMICROBIA; ANIMAL; C57BL MOUSE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION; GENETICS; IMMUNOBLOTTING; LIVER; LIVER RESECTION; METABOLISM; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURGERY;

ADMINISTRATION, ORAL; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BILE ACIDS AND SALTS; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION; HEPATECTOMY; HEPATOCYTES; IMMUNOBLOTTING; KI-67 ANTIGEN; LIVER; LIVER REGENERATION; MALE; MICE, INBRED C57BL; MICROBIOTA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIRTUIN 1; TRETINOIN;

EID: 84957695751     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.6665     Document Type: Article

References (58)

1. Sommer F and Backhed F. The gut microbiota-masters of host development and physiology. Nat Rev Microbiol. 2013; 11:227-238.
2. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S and Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell. 2004; 118:229-241.
3. Dove WF, Clipson L, Gould KA, Luongo C, Marshall DJ, Moser AR, Newton MA and Jacoby RF. Intestinal neoplasia in the Apc(Min) mouse: Independence from the microbial and natural killer (beige locus) status. Cancer Res. 1997; 57:812-814.
4. Swidsinski A, Khilkin M, Kerjaschki D, Schreiber S, Ortner M, Weber J and Lochs H. Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology. 1998; 115:281-286.
5. Cornell RP. Gut-Derived Endotoxin Elicits Hepatotrophic Factor Secretion for Liver-Regeneration. Am J Physiol. 1985; 249:R551-R562.
6. Cornell RP. Restriction of Gut-Derived Endotoxin Impairs DNA-Synthesis for Liver-Regeneration. Am J Physiol. 1985; 249:R563-R569.
7. Cornell RP, Liljequist BL and Bartizal KF. Depressed Liver-Regeneration after Partial-Hepatectomy of Germ-Free, Athymic and Lipopolysaccharide-Resistant Mice. Hepatology. 1990; 11:916-922.
8. Martin FPJ, Dumas ME, Wang YL, Legido-Quigley C, Yap IKS, Tang HR, Zirah S, Murphy GM, Cloarec O, Lindon JC, Sprenger N, Fay LB, Kochhar S, et al. A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol Syst Biol. 2007; 3. 112.
9. Larsen N, Vogensen FK, van den Berg FWJ, Nielsen DS, Andreasen AS, Pedersen BK, Abu Al-Soud W, Sorensen SJ, Hansen LH and Jakobsen M. Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults. Plos One. 2010; 5:e9085.
10. Zupancic ML, Cantarel BL, Liu ZQ, Drabek EF, Ryan KA, Cirimotich S, Jones C, Knight R, Walters WA, Knights D, Mongodin EF, Horenstein RB, Mitchell BD, Steinle N, Snitker S, Shuldiner AR, et al. Analysis of the Gut Microbiota in the Old Order Amish and Its Relation to the Metabolic Syndrome. Plos One. 2012; 7:e43052.
11. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD and Gordon JI. Obesity alters gut microbial ecology. P Natl Acad Sci USA. 2005; 102:11070-11075.
12. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF and Gordon JI. The gut microbiota as an environmental factor that regulates fat storage. P Natl Acad Sci USA. 2004; 101:15718-15723.
13. Ley RE, Turnbaugh PJ, Klein S and Gordon JI. Microbial ecology-Human gut microbes associated with obesity. Nature. 2006; 444:1022-1023.
14. Moschen AR, Kaser S and Tilg H. Non-alcoholic steatohepatitis: a microbiota-driven disease. Trends Endocrin Met. 2013; 24:537-545.
15. Liu HX, Keane R, Sheng L and Wan YY. Implications of microbiota and bile acid in liver injury and regeneration. J Hepatol. 2015; 63:1502-10.
16. Tsuei J, Chau T, Mills D and Wan YJY. Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer. Exp Biol Med. 2014; 239:1489-1504.
17. Heuman DM. Quantitative Estimation of the Hydrophilic Hydrophobic Balance of Mixed Bile-Salt Solutions. J Lipid Res. 1989; 30:719-730.
18. Liu HX, Fang YP, Hu Y, Gonzalez FJ, Fang JW and Wan YJY. PPAR beta Regulates Liver Regeneration by Modulating Akt and E2f Signaling. Plos One. 2013; 8:e65644.
19. DeAngelis RA, Markiewski MM, Taub R and Lambris JD. A high-fat diet impairs liver regeneration in C57BL/6 mice through overexpression of the NF-kappa B inhibitor, I kappa B alpha. Hepatology. 2005; 42:1148-1157.
20. Shteyer E, Liao YJ, Muglia LJ, Hruz PW and Rudnick DA. Disruption of hepatic adipogenesis is associated with impaired liver regeneration in mice. Hepatology. 2004; 40:1322-1332.
21. Uriarte I, Fernandez-Barrena MG, Monte MJ, Latasa MU, Chang HCY, Carotti S, Vespasiani-Gentilucci U, Morini S, Vicente E, Concepcion AR, Medina JF, Marin JJG, Berasain C, et al. Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice. Gut. 2013; 62:899-910.
22. Pean N, Doignon I, Garcin I, Besnard A, Julien B, Liu BK, Branchereau S, Spraul A, Guettier C, Humbert L, Schoonjans K, Rainteau D and Tordjmann T. The Receptor TGR5 Protects the Liver From Bile Acid Overload During Liver Regeneration in Mice. Hepatology. 2013; 58:1451-1460.
23. Liu HX, Hu Y, French SW, Gonzalez FJ and Wan YJ. Forced expression of fibroblast growth factor 21 reverses the sustained impairment of liver regeneration in hPPARalphaPAC mice due to dysregulated bile acid synthesis. Oncotarget. 2015; 6:9686-9700. Doi: 10.18632/oncotarget.3531.
24. Huang WD, Ma K, Zhang J, Qatanani M, Cuvillier J, Liu J, Dong BN, Huang XF and Moore DD. Nuclear receptordependent bile acid signaling is required for normal liver regeneration. Science. 2006; 312:233-236.
25. Sayin SI, Wahlstrom A, Felin J, Jantti S, Marschall HU, Bamberg K, Angelin B, Hyotylainen T, Oresic M and Backhed F. Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-betamuricholic Acid, a Naturally Occurring FXR Antagonist. Cell Metab. 2013; 17:225-235.
26. Swann JR, Want EJ, Geier FM, Spagou K, Wilson ID, Sidaway JE, Nicholson JK and Holmes E. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. P Natl Acad Sci USA. 2011; 108:4523-4530.
27. Kakiyama G, Pandak WM, Gillevet PM, Hylemon PB, Heuman DM, Daita K, Takei H, Muto A, Nittono H, Ridlon JM, White MB, Noble NA, Monteith P, Fuchs M, Thacker LR, Sikaroodi M, et al. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis. J Hepatol. 2013; 58:949-955.
28. Hu Y, Chau T, Liu HX, Liao DG, Keane R, Nie YQ, Yang H and Wan YJY. Bile Acids Regulate Nuclear Receptor (Nur77) Expression and Intracellular Location to Control Proliferation and Apoptosis. Mol Cancer Res. 2015; 13:281-292.
29. He YQ, Gong L, Fang YP, Zhan Q, Liu HX, Lu YL, Guo GL, Lehman-McKeeman L, Fang JW and Wan YJY. The role of retinoic acid in hepatic lipid homeostasis defined by genomic binding and transcriptome profiling. Bmc Genomics. 2013; 14:575.
30. Yang F, He YQ, Liu HX, Tsuei J, Jiang XY, Yang L, Wang ZT and Wan YJY. All-trans retinoic acid regulates hepatic bile acid homeostasis. Biochem Pharmacol. 2014; 91:483-489.
31. Liu HX, Ly I, Hu Y and Wan YJY. Retinoic acid regulates cell cycle genes and accelerates normal mouse liver regeneration. Biochem Pharmacol. 2014; 91:256-265.
32. Tap J, Mondot S, Levenez F, Pelletier E, Caron C, Furet JP, Ugarte E, Munoz-Tamayo R, Le Paslier D, Nalin R, Dore J and Leclerc M. Towards The Healthy Human Intestinal Microbiota Phylogenetic Core? Microb Ecol. 2009; 57:580-581.
33. Halilbasic E, Claudel T and Trauner M. Bile acid transporters and regulatory nuclear receptors in the liver and beyond. J Hepatol. 2013; 58:155-168.
34. Li Y, Wong K, Walsh K, Gao B and Zang MW. Retinoic Acid Receptor beta Stimulates Hepatic Induction of Fibroblast Growth Factor 21 to Promote Fatty Acid Oxidation and Control Whole-body Energy Homeostasis in Mice. J Biol Chem. 2013; 288:10490-10504.
35. Chau MDL, Gao JP, Yang Q, Wu ZD and Gromada J. Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1 alpha pathway. P Natl Acad Sci USA. 2010; 107:12553-12558.
36. Fausto N, Campbell JS and Riehle KJ. Liver regeneration. Hepatology. 2006; 43:S45-S53.
37. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER and Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006; 444:1027-1031.
38. Dubourg G, Lagier JC, Armougom F, Robert C, Audoly G, Papazian L and Raoult D. High-level colonisation of the human gut by Verrucomicrobia following broad-spectrum antibiotic treatment. Int J Antimicrob Ag. 2013; 41:149-155.
39. Sait M, Kamneva OK, Fay DS, Kirienko NV, Polek J, Shirasu-Hiza MM and Ward NL. Genomic and experimental evidence suggests that Verrucomicrobium spinosum interacts with eukaryotes. Front Microbiol. 2011; 2:211.
40. Jalanka-Tuovinen J, Salonen A, Nikkila J, Immonen O, Kekkonen R, Lahti L, Palva A and de Vos WM. Intestinal Microbiota in Healthy Adults: Temporal Analysis Reveals Individual and Common Core and Relation to Intestinal Symptoms. Plos One. 2011; 6:e23035.
41. Tap J, Mondot S, Levenez F, Pelletier E, Caron C, Furet JP, Ugarte E, Munoz-Tamayo R, Paslier DLE, Nalin R, Dore J and Leclerc M. Towards the human intestinal microbiota phylogenetic core. Environ Microbiol. 2009; 11:2574-2584.
42. Vital M, Howe AC and Tiedje JM. Revealing the Bacterial Butyrate Synthesis Pathways by Analyzing (Meta) genomic Data. Mbio. 2014; 5:e00889.
43. Frank DN, Amand ALS, Feldman RA, Boedeker EC, Harpaz N and Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. P Natl Acad Sci USA. 2007; 104:13780-13785.
44. Donohoe DR, Garge N, Zhang XX, Sun W, O'Connell TM, Bunger MK and Bultman SJ. The Microbiome and Butyrate Regulate Energy Metabolism and Autophagy in the Mammalian Colon. Cell Metab. 2011; 13:517-526.
45. Oelkers P, Kirby LC, Heubi JE and Dawson PA. Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2). J Clin Invest. 1997; 99:1880-1887.
46. Heubi JE, Balistreri WF, Fondacaro JD, Partin JC and Schubert WK. Primary bile acid malabsorption: defective in vitro ileal active bile acid transport. Gastroenterology. 1982; 83:804-811.
47. Azcarate-Peril MA, Sikes M and Bruno-Barcena JM. The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer? Am J Physiol-Gastr L. 2011; 301:G401-G424.
48. Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS and Maratos-Flier E. Hepatic fibroblast growth factor 21 is regulated by PPAR alpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 2007; 5:426-437.
49. Inagaki T, Dutchak P, Zhao GX, Ding XS, Gautron L, Parameswara V, Li Y, Goetz R, Mohammadi M, Esser V, Elmquist JK, Gerard RD, Burgess SC, et al. Endocrine regulation of the fasting response by PPAR alpha-mediated induction of fibroblast growth factor 21. Cell Metab. 2007; 5:415-425.
50. Xu J, Lloyd DJ, Hale C, Stanislaus S, Chen M, Sivits G, Vonderfecht S, Hecht R, Li YS, Lindberg RA, Chen JL, Jung DY, Zhang ZY, et al. Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice. Diabetes. 2009; 58:250-259.
51. Fisher FM, Chui PC, Antonellis PJ, Bina HA, Kharitonenkov A, Flier JS and Maratos-Flier E. Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State. Diabetes. 2010; 59:2781-2789.
52. Holecek M. Nutritional modulation of liver regeneration by carbohydrates, lipids, and amino acids: A review. Nutrition. 1999; 15:784-788.
53. Nakatani T, Ozawa K, Asano M, Ukikusa M, Kamiyama Y and Tobe T. Differences in Predominant Energy Substrate in Relation to the Resected Hepatic Mass in the Phase Immediately after Hepatectomy. J Lab Clin Med. 1981; 97:887-898.
54. Hu Y, Zhan Q, Liu HX, Chau T, Li YY and Wan YJY. Accelerated Partial Hepatectomy-Induced Liver Cell Proliferation Is Associated with Liver Injury in Nur77 Knockout Mice. Am J Pathol. 2014; 184:3272-3283.
55. Liu HX, Fang Y, Hu Y, Gonzalez FJ, Fang J and Wan YJ. PPARbeta Regulates Liver Regeneration by Modulating Akt and E2f Signaling. Plos One. 2013; 8:e65644.
56. Meyer M and Kircher M. Illumina sequencing library preparation for highly multiplexed target capture and sequencing. Cold Spring Harbor protocols. 2010; 2010:pdb prot5448.
57. Yang F, Xu Y, Xiong AZ, He YG, Yang L, Wan YJY and Wang ZT. Evaluation of the protective effect of Rhei Radix et Rhizoma against alpha-naphthylisothiocyanate induced liver injury based on metabolic profile of bile acids. J Ethnopharmacol. 2012; 144:599-604.
58. Garcia-Canaveras JC, Donato MT, Castell JV and Lahoz A. Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated method. J Lipid Res. 2012; 53:2231-2241.